13 Feb Portal Bio
Anil Narasimha, Ph.D., Chief Commercial Officer
April 16 | 10:00am | Salone dei Cavalieri, Section 2
Watertown, Massachusetts
(Private)
Portal is a cell engineering platform company focused on enabling next generation cell engineering and analytics across research and clinical applications. The company is implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and molecular design technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The process relies on transient perturbation of a cell’s membrane as it transits through microscopic holes in a thin, specially designed, silicon surface. The technology’s ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics. The company currently has over 50 partners, including many of the top pharma companies.
